Physician

Brooke E Brander, DO

According to 2025 Medicare claims, Brooke Brander, DO (NPI: 1083838239) practices hematology/oncology in the Fayetteville-Springdale-Rogers, AR market, with the plurality of this provider's patient population coming from Washington, AR. This provider's primary affiliated billing organization is HIGHLANDS ONCOLOGY GROUP PA (NPI: 1346211323; TIN: 710788742) and primary practice location at 72703-4005. Brander is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616), participating under the MSSP model.

Brander's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,418 traditional Medicare patients, billed 204,304 HCPCS/CPT codes, and received $3,383,949 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 2,148 prescription claims across 394 beneficiaries totaling $3,011,533 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 39 claims. Open Payments data shows 67 records totaling $1,350. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $563,633 to $3,011,533. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,411 and ending at $13,129.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	932	108,104	$1,386,204
2016	1,168	225,154	$2,699,718
2017	1,268	221,217	$2,765,950
2018	1,408	307,831	$4,119,847
2019	1,574	334,555	$4,736,268
2020	1,373	303,890	$4,622,111
2021	1,448	338,562	$5,162,584
2022	1,325	253,178	$4,044,711
2023	1,188	218,701	$3,514,867
2024	1,418	204,304	$3,383,949

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	292	1,443	$563,633
2016	352	1,639	$726,985
2017	414	1,911	$903,594
2018	384	2,029	$1,733,748
2019	562	2,405	$2,684,347
2020	548	2,215	$2,655,826
2021	526	2,539	$2,943,430
2022	424	2,319	$1,957,161
2023	438	2,117	$1,729,710
2024	394	2,148	$3,011,533

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	55	$1,791
2017	N/R	30	$1,718
2018	N/R	36	$2,079
2019	N/R	36	$2,055
2020	N/R	56	$2,212
2021	N/R	72	$3,837
2022	N/R	50	$2,246
2023	N/R	42	$2,513
2024	N/R	39	$2,255

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	647	1,750	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	681	1,848	$8
83735	Magnesium level	629	1,710	$6
83615	Lactate dehydrogenase (enzyme) level	627	1,710	$6
84100	Phosphate level	628	1,713	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	38	1,200	$670,804
Ibrance	Palbociclib	33	923	$510,290
Imbruvica	Ibrutinib	23	700	$395,676
Kisqali	Ribociclib Succinate	17	476	$286,910
Brukinsa	Zanubrutinib	17	510	$218,766

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	20	$1,893
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	19	$362

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	67	$1,350	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brooke E. Brander, DO?

Tedicare shows public-source Medicare data for Brooke E. Brander, DO (NPI 1083838239), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brooke E. Brander, DO have ACO affiliation data?

Brooke E. Brander, DO is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616).

What billing organization is linked to Brooke E. Brander, DO?

Brooke E. Brander, DO is linked to HIGHLANDS ONCOLOGY GROUP PA (billing NPI 1346211323) in the available physician profile data.

Does Brooke E. Brander, DO have Open Payments data?

Brooke E. Brander, DO has 67 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.